Darryl Jones has over 15 years of capital market experience with a well-established financial network. Prior to joining Isracann in 2018, Mr. Jones was an investment advisor with PI Financial Corp Canada. At PI Financial, he raised seed capital and took True Leaf Medicine (CSE: MJ/OTC: TRLFF) public in early 2014 at $10MM valuation and exited in 2016 at $150MM market capitalization. Mr. Jones also worked at Raymond James Ltd Canada where he was involved in structuring and financing well over 20 acquisitions from medical to health sciences to mineral exploration in agnostic platform deals. Mr. Jones currently serves on several other public company boards including Strikepoint Gold (TSXV: SKP/OTC: STKXF) and Voltaic Minerals Corp. (TSXV: VLT/OTC: VTCCF).